Literature DB >> 10532394

Immunomodulatory function of lactic acid bacteria.

H Yasui1, K Shida, T Matsuzaki, T Yokokura.   

Abstract

Using mice, we found that oral administration of Bifidobacterium breve YIT4064 (B. breve) activated the humoral immune system, augmented anti-rotavirus IgA production or anti-influenza virus (IFV) IgG production and protected against rotavirus infection or influenza infection, respectively. Furthermore, when the B. breve was given to infants from an infant home, there was a significant reduction of the frequency of rotavirus shedding in stool samples during the administration of the bacteria. It was also found, again using mice, that oral administration of Lactobacillus casei strain Shirota (LcS) stimulated type 1 helper T (Th1) cells, activated the cellular immune system and inhibited incidence of tumors and IgE production. These results demonstrated that these two strains of lactic acid bacteria modulated the different immune systems each in its own way and prevented against various diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532394

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  28 in total

1.  Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages.

Authors:  L S Wang; H M Zhu; D Y Zhou; Y L Wang; W D Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Effects of probiotic supplementation on markers of acute pancreatitis in rats.

Authors:  Nara L Horst; Ruy Garcia Marques; Cristina F Diestel; Bianca D Matzke; Carlos Eduardo R Caetano; Fernanda Correia Simões; Arnaldo F B Andrade; Wagner I Lobão; Luiz Carlos A Vaz; Margareth C Portela; José Ueleres Braga; Paulo A Melo
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

3.  Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.

Authors:  T Hori; J Kiyoshima; K Shida; H Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 4.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

5.  Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.

Authors:  Ke Wen; Marli S P Azevedo; Ana Gonzalez; Wei Zhang; Linda J Saif; Guohua Li; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

Review 6.  Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.

Authors:  Alessandro Di Cerbo; Federica Pezzuto; Lucia Palmieri; Valentina Rottigni; Tommaso Iannitti; Beniamino Palmieri
Journal:  Int Urol Nephrol       Date:  2013-04-13       Impact factor: 2.370

7.  Perceptions of medical sciences students towards probiotics.

Authors:  Laleh Payahoo; Zeinab Nikniaz; Reza Mahdavi; Mohamad Asghari Jafar Abadi
Journal:  Health Promot Perspect       Date:  2012-07-01

8.  Development of γδ T cell subset responses in gnotobiotic pigs infected with human rotaviruses and colonized with probiotic lactobacilli.

Authors:  Ke Wen; Guohua Li; Wei Zhang; Marli S P Azevedo; Linda J Saif; Fangning Liu; Tammy Bui; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2011-03-23       Impact factor: 2.046

9.  Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota.

Authors:  Hisako Yasui; Junko Kiyoshima; Tetsuji Hori
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

Authors:  D Sgouras; P Maragkoudakis; K Petraki; B Martinez-Gonzalez; E Eriotou; S Michopoulos; G Kalantzopoulos; E Tsakalidou; A Mentis
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.